Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

SpringWorks Therapeutics Reported Q4 OGSIVEO Net Product Revenues of $5.4M, EPS Loss of $(1.44) Vs $(1.19) YoY, Cash of $662.6M

Author: Benzinga Newsdesk | February 27, 2024 07:39am

Posted In: SWTX